The FDA has nothing to do with the use of hydroxychloroquine for this disease.
Nothing at all.
Studies have to be done, are being done, will be done, and when they are submitted to the FDA SARS-CoV-2 will become an FDA indication for HCQ.
But the absence of an FDA indication has ZERO impact on current clinical practice
And don’t we have the “right to try” now?